Mimetica Overview
- Year Founded
-
2001
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Mimetica General Information
Description
Developer of a drug discovery platform designed to treat acne. The company's platform is based on the rational design of small molecules that mimic natural peptide hormones, enabling users to get flawless skin.
Contact Information
Website
www.mimetica.com.auOwnership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
- Level 19 HWT Tower
- 40 City Road
- Melbourne, Victoria 3006
- Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
- Level 19 HWT Tower
- 40 City Road
- Melbourne, Victoria 3006
- Australia
Mimetica Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 19-Apr-2021 | Completed | Out of Business | |||
| 4. Later Stage VC | 07-Mar-2014 | Completed | Clinical Trials - Phase 2 | |||
| 3. Reverse Merger | 22-Oct-2013 | Cancelled | Generating Revenue | |||
| 2. Later Stage VC | 01-Jan-2013 | $1.5M | $1.5M | Completed | Generating Revenue | |
| 1. Later Stage VC | 01-May-2007 | Completed | Generating Revenue |
Mimetica Patents
Mimetica Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20120141392-A1 | Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor | Inactive | 27-Feb-2009 | ||
| US-20140128380-A1 | Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor | Inactive | 27-Feb-2009 | ||
| WO-2010096853-A1 | Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor | Inactive | 27-Feb-2009 | ||
| WO-2010096854-A1 | Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors | Inactive | 27-Feb-2009 | ||
| JP-2011513244-A | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonist | Active | 29-Feb-2008 | C07D243/08 |
Mimetica FAQs
-
When was Mimetica founded?
Mimetica was founded in 2001.
-
Where is Mimetica headquartered?
Mimetica is headquartered in Melbourne, Australia.
-
What industry is Mimetica in?
Mimetica’s primary industry is Drug Discovery.
-
Is Mimetica a private or public company?
Mimetica is a Private company.
-
What is Mimetica’s current revenue?
The current revenue for Mimetica is .
-
How much funding has Mimetica raised over time?
Mimetica has raised $7.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process